[Loss of CD45 expression at relapse of acute myeloid leukemia]

Rinsho Ketsueki. 2017;58(8):938-941. doi: 10.11406/rinketsu.58.938.
[Article in Japanese]

Abstract

A 49-year-old female was initially diagnosed with acute myeloid leukemia (AML) M4 with a CD45+CD13+CD33+CD34-HLA-DR+ immunophenotype. She underwent allogeneic bone marrow transplantation, but the disease recurred. The bone marrow was infiltrated with 87.0% blasts negative for myeloperoxidase (MPO) staining. Immunophenotyping by flow cytometry identified the presence of a CD45-negative blast population. These blasts exhibited a CD13+CD33+CD19-CD10-CD34-HLA-DR- immunophenotype. The lack of CD45 expression is often observed in B-cell acute lymphoblastic leukemia, whereas CD45-negative AML is extremely rare; only one older male with AML-M0 has been reported. In the present case, the CD45-negative blasts had an MPO-CD13+CD33+ phenotype, which is similar to AML-M0.

Keywords: Acute myeloid leukemia; CD45-negative; Flow cytometry; M0.

Publication types

  • Case Reports

MeSH terms

  • Fatal Outcome
  • Female
  • Flow Cytometry
  • Humans
  • Leukemia, Myeloid, Acute / immunology*
  • Leukemia, Myeloid, Acute / pathology
  • Leukocyte Common Antigens / analysis*
  • Leukocyte Common Antigens / deficiency
  • Leukocyte Common Antigens / immunology
  • Middle Aged

Substances

  • Leukocyte Common Antigens
  • PTPRC protein, human